UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
SLS holding history
SELLAS Life Sciences Group, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SLS overviewAll 13F holders of SLSFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,252,757
- Value
- $18.5M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,252,757 | $18.5M | <0.1% | +507,338+68.1% | Added | Holders |
| Q1 2026 | 745,419 | $3.15M | <0.1% | +696,692+1,429.8% | Added | Holders |
| Q4 2025 | 48,727 | $183.7K | <0.1% | −36,262−42.7% | Reduced | Holders |
| Q3 2025 | 84,989 | $136.8K | <0.1% | −224,698−72.6% | Reduced | Holders |
| Q2 2025 | 309,687 | $678.2K | <0.1% | +247,456+397.6% | Added | Holders |
| Q1 2025 | 62,231 | $67.2K | <0.1% | −65,590−51.3% | Reduced | Holders |
| Q4 2024 | 127,821 | $132.9K | <0.1% | +127,821 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −26−100.0% | Sold out | Holders |
| Q3 2023 | 26 | $43 | <0.1% | +26 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −1,359−100.0% | Sold out | Holders |
| Q3 2022 | 1,359 | $3.00K | <0.1% | +1,359 | New | Holders |